1. Clinical and epidemiological features of psoriasis exacerbations in children with SARS‐CoV‐2 infection.
- Author
-
Skrek, S., Di Lernia, V., Beauchet, A., Bursztejn, A.‐C., Belloni Fortina, A., Lesiak, A., Thomas, J., Brzezinski, P., Topkarci, Z., Murashkin, N., Torres, T., Epishev, R., Chiriac, A., McPherson, T., Akinde, M., Maruani, A., Luna, P. C., Vidaurri de la Cruz, H., Mallet, S., and Leducq, S.
- Subjects
PSORIASIS ,ENTEROVIRUS diseases ,SARS-CoV-2 ,DISEASE exacerbation ,INFECTION - Abstract
A trend (factors used for multivariate analysis, I p i < 0.20) was observed for females ( I p i = 0.09), younger age ( I p i = 0.11), history of psoriatic arthritis ( I p i = 0.12) and use of systemic treatments ( I p i = 0.07), including use of biologic therapies ( I p i = 0.17) (Table 1). Flares were defined as exacerbation of psoriasis within 1 month after the onset of SARS-CoV-2 infection. Psoriasis worsened within 1 month of infection in 25 (17.7%) children and 26 (17.5%) SARS-CoV-2-infections (Table 1). 1 TABLE Risk factors for psoriasis flares after SARS-CoV-2 infection. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF